Arcoma AB (Sweden) Probability of Future Stock Price Finishing Over 13.26
| ARCOMA Stock | SEK 10.65 0.20 1.84% |
Arcoma |
Arcoma AB Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arcoma AB for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arcoma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Arcoma AB generated a negative expected return over the last 90 days | |
| The company reported the revenue of 117.13 M. Net Loss for the year was (7.47 M) with profit before overhead, payroll, taxes, and interest of 55.29 M. | |
| Arcoma AB has accumulated about 811 K in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Roughly 47.0% of the company shares are held by company insiders |
Arcoma AB Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arcoma Stock often depends not only on the future outlook of the current and potential Arcoma AB's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcoma AB's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.4 M | |
| Cash And Short Term Investments | 4.8 M |
Arcoma AB Technical Analysis
Arcoma AB's future price can be derived by breaking down and analyzing its technical indicators over time. Arcoma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arcoma AB. In general, you should focus on analyzing Arcoma Stock price patterns and their correlations with different microeconomic environments and drivers.
Arcoma AB Predictive Forecast Models
Arcoma AB's time-series forecasting models is one of many Arcoma AB's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Arcoma AB's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Arcoma AB
Checking the ongoing alerts about Arcoma AB for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arcoma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Arcoma AB generated a negative expected return over the last 90 days | |
| The company reported the revenue of 117.13 M. Net Loss for the year was (7.47 M) with profit before overhead, payroll, taxes, and interest of 55.29 M. | |
| Arcoma AB has accumulated about 811 K in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.06. | |
| Roughly 47.0% of the company shares are held by company insiders |
Other Information on Investing in Arcoma Stock
Arcoma AB financial ratios help investors to determine whether Arcoma Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arcoma with respect to the benefits of owning Arcoma AB security.